Poole Jonathan
Insider CIK 1604689 · ACAD Director · GNCA Chief Financial Officer · EVLO CFO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2026-05-29 | 2026-06-01 | 2,010 | — | $0 | 0 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2026-05-29 | 2026-06-01 | 16,004 | — | $0 | 16,004 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2026-05-29 | 2026-06-01 | 9,311 | — | $0 | 9,311 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2026-05-29 | 2026-06-01 | 2,010 | — | $0 | 2,010 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2026-03-03 | 2026-03-20 | 2,010 | — | $0 | 2,010 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2026-03-03 | 2026-03-20 | 7,482 | — | $0 | 7,482 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2026-03-03 | 2026-03-20 | 3,565 | — | $0 | 3,565 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2026-03-03 | 2026-03-20 | 4,218 | — | $0 | 4,218 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | A Award deriv | 2020-01-28 | 2020-01-30 | 48,000 | — | $0 | 48,000 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | A Award deriv | 2020-01-28 | 2020-01-30 | 106,000 | — | $0 | 106,000 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | A Award deriv | 2019-01-14 | 2019-01-16 | 100,000 | — | $0 | 100,000 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | A Award deriv | 2018-05-08 | 2018-05-10 | 71,497 | — | $0 | 71,497 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | A Award deriv | 2018-02-08 | 2018-02-12 | 217,708 | — | $0 | 217,708 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | M Exercise deriv | 2017-07-24 | 2017-07-24 | 45,000 | — | $0 | 90,000 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | S Sale | 2017-07-24 | 2017-07-24 | 45,000 | $6.00 | $270.0K | 39,247 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | M Exercise | 2017-07-24 | 2017-07-24 | 45,000 | $3.09 | $139.1K | 84,247 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | F Tax w/h | 2017-05-10 | 2017-05-10 | 3,500 | $6.13 | $21.5K | 39,247 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | S Sale | 2017-05-08 | 2017-05-10 | 6,213 | $6.51 | $40.4K | 42,747 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | A Award | 2017-05-03 | 2017-05-10 | 7,937 | — | $0 | 25,150 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | A Award | 2017-05-03 | 2017-05-10 | 23,810 | — | $0 | 48,960 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | A Award deriv | 2017-02-28 | 2017-03-01 | 135,000 | — | $0 | 135,000 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | P Buy | 2016-11-07 | 2016-11-09 | 7,000 | $3.34 | $23.4K | 17,213 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | P Buy | 2016-05-09 | 2016-05-10 | 4,000 | $3.88 | $15.5K | 8,213 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | A Award deriv | 2016-02-02 | 2016-02-04 | 135,000 | — | $0 | 135,000 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | A Award deriv | 2015-02-26 | 2015-03-02 | 95,000 | — | $0 | 95,000 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | A Award deriv | 2014-04-07 | 2014-12-15 | 200,726 | — | $0 | 200,726 | SEC↗ |